CAMCE(SZ:002051)2021-04-28 16:00Financial Performance - The company's operating revenue for Q1 2021 was ¥1,670,432,089.57, representing a 4.13% increase compared to ¥1,604,234,557.49 in the same period last year[9]. - Net profit attributable to shareholders was ¥68,080,400.69, a significant increase of 199.54% from ¥22,728,095.88 in the previous year[9]. - The net profit after deducting non-recurring gains and losses was ¥58,754,238.73, up 55.06% from ¥37,890,101.15 year-on-year[9]. - The basic earnings per share rose to ¥0.06, a 200.00% increase compared to ¥0.02 in the same period last year[9]. - In Q1 2021, the company's revenue increased by 4.13% year-on-year, while net profit attributable to shareholders surged by 199.54% due to a low base from Q1 2020 impacted by COVID-19[23]. - Net profit for the current period was ¥64,351,094.17, significantly higher than ¥7,656,842.83 in the previous period, marking an increase of 740.5%[70]. - The profit attributable to shareholders of the parent company was ¥68,080,400.69, compared to ¥22,728,095.88 in the previous period, representing an increase of 199.5%[70]. - Other comprehensive income after tax for the current period was ¥32,138,092.37, a recovery from a loss of ¥54,304,083.31 in the previous period[70]. - The total comprehensive income for the current period is 49,296,132.66, compared to 77,417,336.85 in the previous period, showing a decrease of approximately 36.3%[80]. Assets and Liabilities - The total assets at the end of the reporting period were ¥21,740,275,865.08, reflecting a 0.26% increase from ¥21,682,851,389.56 at the end of the previous year[9]. - Total liabilities decreased to ¥10,948,174,917.88 from ¥10,988,220,628.90, a decline of about 0.36%[54]. - Current liabilities totaled ¥9,889,072,247.16, down from ¥10,576,611,112.49, showing a decrease of approximately 6.50%[54]. - The total owner's equity increased to ¥10,792,100,947.20 from ¥10,694,630,760.66, reflecting a growth of approximately 0.91%[57]. - The company's long-term borrowings increased to ¥125,220,796.83 from ¥101,825,067.09, representing a growth of 22.87%[54]. - Total liabilities rose from 10,988,220,628.90 to 11,619,375,854.30, an increase of 631,155,225.40[98]. - The company's total equity remained stable at 10,694,630,760.66, indicating no change in shareholder equity[98]. Cash Flow - The net cash flow from operating activities improved to -¥717,569,098.86, a 5.51% improvement from -¥759,438,931.58 in the same period last year[9]. - Cash inflows from operating activities totaled 1,816,924,827.76, an increase from 1,678,540,202.36 in the previous period, representing a growth of about 8.3%[85]. - Cash outflows from operating activities amounted to 2,534,493,926.62, compared to 2,437,979,133.94 in the previous period, indicating an increase of approximately 4.0%[85]. - The company's cash and cash equivalents decreased to ¥3,963,663,447.53 from ¥4,121,811,059.87, a decline of about 3.84%[58]. - Cash and cash equivalents at the end of the period stand at 6,613,950,701.60, down from 6,775,619,541.14 in the previous period, reflecting a decrease of about 2.4%[87]. - The company received cash from sales of goods and services amounting to 1,626,504,080.14, compared to 1,548,009,878.71 in the previous period, marking an increase of approximately 5.0%[81]. - The company reported a cash inflow from financing activities of 49,706,224.37, compared to 109,530,500.00 in the previous period, reflecting a decline of approximately 54.7%[87]. - Net cash flow from investing activities was -464,894.69, a significant decrease compared to -84,801.39 from the previous period[91]. Investments and Contracts - The company signed a total of two significant contracts during the reporting period, including a contract worth ¥597.20 million for a school construction project and another worth ¥31.98 million for a hospital design project[24]. - The company transferred 51% equity of a subsidiary for ¥177.66 million to optimize resource allocation, with the transaction completed on April 1, 2021[24]. - The fair value of the company's investment in 蓝科高新 was reported at ¥40.60 million as of March 31, 2021, reflecting a gain of ¥9.59 million during the reporting period[30]. - The fair value of other equity investments held by the company amounted to ¥53.60 million as of March 31, 2021[31]. Risk Management - The company has implemented a risk management framework for its forward foreign exchange contracts to mitigate currency fluctuation risks[37]. - The company has established a set of guidelines for managing forward foreign exchange transactions, which includes approval processes and risk management measures[37]. - The fair value of derivatives is primarily based on contracts with banks, with specific valuation methods and assumptions disclosed[38]. - The company reported no significant changes in accounting policies for derivatives compared to the previous reporting period[38]. - There were no major operational contracts or entrusted financial management activities reported during the period[39][40]. - The company has no violations regarding external guarantees or non-operational fund occupation by controlling shareholders during the reporting period[41][42]. Research and Development - Research and development expenses for the current period were ¥49,836,506.14, down from ¥58,964,924.48, indicating a decrease of 15.5%[67].